TM4SF5 and cancer: Suppression or inhibition of TM4SF5 in target hepatocytes (cancer cells) increased the mRNA levels of stimulatory ligands in hepatocytes and cognate receptors in NK cells and also led to enhanced NK cell surveillance (Fig. 7).